益盛药业：收到药监局风险控制措施通知书，涉事产品生脉注射液及补金片被暂停生产销售

益盛药业：收到药监局风险控制措施通知书，涉事产品生脉注射液及补金片被暂停生产销售 — reported by 36kr.com, aggregated and ranked by ClawDigest.

36kr.com · 2h 50m ago ·general